Skip to main content

Day: January 19, 2022

HCW Biologics’ Founder and CEO Dr. Hing C. Wong Participating in Cambridge Healthtech Institute’s Annual PepTalk Conference 2022

A Novel Platform to Create Multi-Functional Immunotherapeutics for Cancer Will Feature TOBI™ Discovery Platform and Lead Product Candidate, HCW9218 MIRAMAR, Fla., Jan. 19, 2022 (GLOBE NEWSWIRE) — HCW Biologics Inc. (“HCW Biologics” or the “Company”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, today announced that Hing C. Wong, Ph.D., Founder and CEO of HCW Biologics, will speak at the Cambridge Healthtech Institute’s 24th Annual PepTalk Conference to be held on January 17-19, 2022 (https://www.chi-peptalk.com/protein-expression-production). The conference is taking place virtually and in person at the Hilton San Diego Bayfront in San Diego, California. Dr. Wong’s...

Continue reading

Medolife Rx Submits Final Clinical Trial Data for Escozine Approval as a COVID-19 Treatment in The Dominican Republic

BURBANK, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Medolife Rx, Inc. (“Medolife”), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today that the Company submitted the final clinical trial data to the Dominican Republic (“DR”) Ministry of Health (“MoH”) for approval of the Company’s product, Escozine, as a COVID-19 treatment. The product, which is registered as an alternative oncological medicine in the DR, has shown to be effective against variations of the SARS-CoV-2 virus. After the recent meeting between Medolife CEO Dr. Mikaelian and DR Vice-President Raquel Peña de Antuña that concluded with interest from the government to register the product as a...

Continue reading

Shareholder Update: GSP Resource Corp. 2021 Review and 2022 Outlook

Vancouver, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) — GSP Resource Corp. (TSX-V: GSPR) (FRA: 0YD) (the “Company” or “GSP”) provides shareholders with the following outlook for 2022 and review of 2021 activities. GSP’s core asset is an option to acquire a 100% interest in the past producing Alwin Copper Mine located in BC’s Highland Valley Copper Camp. Simon Dyakowski CEO of GSP commented: “GSP had a productive year in 2021. Despite logistical challenges driven by poor weather with the Summer wildfires and Autumn flooding, GSP was able to complete approximately 2,300 meters of diamond drilling (8 holes), bringing GSP’s total drilling at the Alwin Mine Project to approximately 4,300 meters (18 holes) over the previous two exploration seasons. Other milestones achieved at Alwin last year include obtaining an important 5-year...

Continue reading

WISeKey Signs Agreement with Universa Blockchain to join the La Linea, Gibraltar 4th Industrial Revolution Center of Excellence

WISeKey Signs Agreement with Universa Blockchain to join the La Linea, Gibraltar 4th Industrial Revolution Center of Excellence Geneva, Moscow, Gibraltar, La Linea – January 19, 2022 – WISeKey International Holding Ltd (“WISeKey “) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, AI, Blockchain and IoT company, announces the signing of a strategic partnership with Universa Blockchain. The agreement includes deep cooperation at the La Linea Gibraltar 4th Industrial Revolution Center of Excellence (LLG 4IR). It was created following the signing of two Memoranda of Understanding (MoUs) with Mr. Fabian Picardo, Chief Minister of Gibraltar and the Mayor of La Línea de la Concepción, Mr. Juan Franco, to spearhead innovation in the region. The parties will unite joint efforts in the breakthrough directions of Advanced Air Mobility (AAM),...

Continue reading

Vodafone Turkey Selects Amdocs for Quality Engineering Transformation with Automated Agile/DevTestOps Approach

Three-year deal will modernize Vodafone Turkey’s testing processes, delivering on operator’s digital vision for a better customer experience JERSEY CITY, N.J., Jan. 19, 2022 (GLOBE NEWSWIRE) — Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today announced it has been selected by Vodafone Turkey to transform and automate the operator’s testing activity in line with Vodafone’s group-wide Tech 2025 modernization journey. The three-year deal for end-to-end quality engineering services will enable Vodafone Turkey to create a next-generation quality engineering organization by establishing a Testing Center of Excellence. This will embrace an Agile/DevTestOps ‘shift-left’ approach to testing – ensuring faster time to market, improved productivity and operational efficiency. As...

Continue reading

Labrador Gold Announces Doubling of Drill Program to 100,000 Metres and Increase to Five Drill Rigs

Targets entire strike length of Appleton Fault ZoneFigure 1.Gold anomalies, occurrences, and drill targets along the Appleton Fault Zone.TORONTO, Jan. 19, 2022 (GLOBE NEWSWIRE) — Labrador Gold Corp. (TSX.V:LAB | OTCQX:NKOSF | FNR: 2N6) (“LabGold” or the “Company”) is pleased to announce a significant increase to its diamond drilling program, at the 100% controlled Kingsway project near Gander, Newfoundland. This increase follows the Company’s success exploring along the Appleton Fault Zone over the past 18 months. The Kingsway project is located in the highly prospective central Newfoundland gold belt. LabGold plans to double the current drilling program to 100,000 metres which includes the outstanding 23,000 metres remaining in the current 50,000 metre program. Four diamond drill rigs are currently operating...

Continue reading

VYNE Therapeutics Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Treatment of Mild-to-Moderate Atopic Dermatitis

Systemic bioavailability of JAK inhibitor (tofacitinib) and S1P receptor modulator (fingolimod) in topical formulation substantially lower compared to oral equivalents Mean Cmax of tofacitinib 50-fold and 1500-fold lower at Day 1 and 14 of study compared to the lowest commercially available oral alternative Findings from Phase 1b safety portion of study support trial continuation Topline Phase 2a results expected in Q1 2022 BRIDGEWATER, N.J., Jan. 19, 2022 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that it has completed the Phase 1b portion of a Phase 1b/2a clinical trial evaluating FMX114 for the treatment of mild-to-moderate atopic dermatitis (AD) (Study VY2021-01). FMX114 is VYNE’s proprietary investigational combination gel formulation of tofacitinib and fingolimod. The...

Continue reading

Oportun and Sezzle Partnering to Give Consumers More Choice in Financing Purchases

Buy Now Pay Later leader becomes Oportun’s first digital-only Lending-as-a-Service partner SAN CARLOS, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT), a mission-driven fintech company, and Sezzle (ASX: SZL), a leading mission-driven Buy Now Pay Later (BNPL) solution, today announced a partnership that will provide consumers more choice when financing higher value purchases at many of Sezzle’s 44,000 online merchant partners. “This is a significant expansion of our Lending-as-a-Service platform, and we are excited to welcome Sezzle as our first digital-only partner,” said Matt Jenkins, COO of Oportun. “Importantly, both of our companies are mission-aligned and committed to providing consumers with responsible, affordable, and transparent financing options that will help them build a credit history.” Through the...

Continue reading

Xali Gold Commences Applications for Drilling Permits at El Oro, Mexico

VANCOUVER, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) — Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the “Company”) is pleased to announce that it has started a new drilling permit application process for the 100% held El Oro gold-silver Project in Mexico. New drill targets have been identified by using a three-dimensional (“3D”) Leapfrog model and are designed to test potential extensions to high-grade gold and silver zones intersected by previous drilling. Some of the higher grades were found in several veins with overlying lower grade disseminated gold near the Mexico-Esperanza Mines border area of the San Rafael vein. The Mexico-Esperanza high-grade intersections at the El Oro Project include: – 16.7g/t Au & 32.5g/t Ag over 1.4m– 30.7g/t Au & 3.0g/t Ag over 1.9m– 12.8g/t Au & 44.0g/t...

Continue reading

Aemetis CEO to Present to Institutional Investors at 27th Annual Credit Suisse Energy Summit Feb. 28th in Vail, Colorado

Company to Review Recently Announced $5 Billion of Offtake Contracts for SAF and RD CUPERTINO, CA , Jan. 19, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, announced that Chairman and CEO Eric McAfee will provide an overview of the Aemetis Dairy RNG, Aviation Fuel, Renewable Diesel, Ethanol and Carbon Sequestration businesses at the 27th Annual Credit Suisse Energy Summit which will be held at the Grand Hyatt Vail in Vail, Colorado on February 28, 2022.    McAfee will present on the topic “$5 billion of New Contracts for Aemetis Carbon Zero Renewable Fuels: Sustainable Aviation Fuel, Renewable Diesel, Dairy RNG, Ethanol, Biodiesel, CO2 Sequestration.”  The Aemetis Carbon Zero, 90 million gallons per year,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.